Rifampin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of tuberculosis (TB). Rifampin is also FDA-approved to treat people who carry Neisseria meningitidis bacteria but have no symptoms of disease. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Rifaldin, Rifoldine, Rifa, Rifampicinum and Riforal. Its PubChem CID is 135398735.
Rifampicin
| CAS No | 13292-46-1 |
|---|---|
| Molecular Formula | C43H58N4O12 |
| Molecular Weight | 822.9 g/mol |
| Synonyms | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment of tuberculosis (TB). Rifampin is also FDA-approved to treat people who carry Neisseria meningitidis bacteria but have no symptoms of disease.
The listed CAS number is 13292-46-1.
The listed molecular formula is C43H58N4O12.
The listed molecular weight is 822.9 g/mol.
[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.
The source lists Rifaldin, Rifoldine, Rifa, Rifampicinum and Riforal.